Skip to main content

Table 1 Demographic, clinical and virological features of the 82 HIV-HCV co-infected patients who fulfilled the inclusion criteria

From: HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study

Variables

Results

Age (years)1

48 (±6)

Male, n (%)2

62 (75.6)

HCV Genotype 1, n (%)2

48 (58.5)

Previous HCV therapy, n (%)2

17 (20.7)

Advanced liver fibrosis, n (%)2

19 (23.2)

CD4 cell count at T11 (cells/mm3)

576 (±280)

CD4 cell count at T21 (cells/mm3)

654 (±351)

HCV RNA at T11 (IU/ml)

3924650 (±5320177)

HCV RNA at T21 (IU/ml)

3085128 (±3372347)

Ongoing ART at T22, n (%)

73 (89)

Clean IFU, n (%)2

39 (47.6)

Clean FFU5, n (%)2

57 (69.5)

Discordant HIV RNA suppression at IFU4, n (%)

14 (17.1)

IL 28B CC genotype, n (%)2

20 (31.7)

  1. 1mean and SD; 2absolute number and percentage respect to all included patients.
  2. ART: Anti Retroviral Therapy; Clean IFU: HIV viremia undetectable during initial follow-up (0-24 months from T1), regardless of being on ART; Clean FFU: HIV viremia undetectable during final follow-up (24-36 months from T1), regardless of being on ART.
  3. Data on IL28B genotype were available for the 63 patients (76.8%).
Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us